Allarity Therapeutics expands in-house lab to add proteomics, cell line research
Expansion adds proteomics and cell line research capabilities, broadens external services and is not expected to change cash runway.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Expanded laboratory capabilities support deeper mechanism-of-action research for stenoparib- New proteomics and cell line capabilities will broaden Allarity’s research capabilities to enable external partnershipsTARPON SPRINGS, Fla., September 28, 2026 — Allarity Therapeutics, Inc. (“Allarity” or…
Allarity Therapeutics expands laboratory capabilities
Allarity Therapeutics said it is expanding laboratory capabilities to include proteomics and cell line research.